Looking Back Over the Last 30 Years, What Advance Has Had the Greatest Impact on the Industry — And Why? Press / Joel E Looking Back Over the Last 30 Years, What Advance Has Had the Greatest Impact on the Industry — And Why? Read More »
The Vanishing Physical Exam in Oncology Press / Joel E The Vanishing Physical Exam in Oncology Read More »
Women in STEM: Early Phase Drug Development Press / Joel E Women in STEM: Early Phase Drug Development Read More »
Assigned Slot Allocation Offers A Fair Solution For Oncology Phase 1 Trial Sponsors, Patients And Providers (Part 2) Press / Joel E Assigned Slot Allocation Offers A Fair Solution For Oncology Phase 1 Trial Sponsors, Patients And Providers (Part 2) Read More »
Slot Allocation Is A Problem For Patients And PIs In Phase 1 Oncology Trials (Part 1) Press / Joel E Slot Allocation Is A Problem For Patients And PIs In Phase 1 Oncology Trials (Part 1) Read More »
IndustrySense Panel Discussion: Early-Phase Oncology Trials: Shaping the Future of Cancer Research Press / Joel E IndustrySense Panel Discussion: Early-Phase Oncology Trials: Shaping the Future of Cancer Research Read More »
Fine-tuning ADCs to Improve Outcomes for Patients with Cancer Press / Joel E Fine-tuning ADCs to Improve Outcomes for Patients with Cancer Read More »
Jorge L. Ramon-Patino, MD, PhD Europe, Principal Investigators, Rioja, Spain / Joel E Jorge L. Ramon-Patino, MD, PhD Read More »
Henry Q. Xiong, MD, PhD Dallas Fort Worth, Principal Investigators, United States / Joel E Henry Q. Xiong, MD, PhD Read More »
Salwan Al Mutar, MD, MSc Dallas Fort Worth, Principal Investigators, United States / Joel E Salwan Al Mutar, MD, MSc Read More »